News
Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key ...
Zacks Investment Research on MSN1d
JAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?Share price of JAZZ Pharmaceuticals JAZZ hit $102.82 on Tuesday, close to its 52-week low of $99.06. This decline is ...
UBS upgraded Jazz Pharmaceuticals (JAZZ) to Buy from Neutral with a price target of $179, up from $145. The company’s base business strength and Ziihera pipeline catalysts boost confidence that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback